trending Market Intelligence /marketintelligence/en/news-insights/trending/evxomwfqkiyamlt0ktabia2 content esgSubNav
In This List

Report: Novo Nordisk mulling 3,000 job cuts to cope with US market conditions

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Report: Novo Nordisk mulling 3,000 job cuts to cope with US market conditions

Novo Nordisk A/S is considering the elimination of up to 3,000 jobs due to tough market conditions in the U.S. market, Reuters reported, citing Danish daily Borsen.

The Danish drugmaker is also contemplating dropping its long-term financial goals and will disclose a cost-cutting plan during the presentation of its second-quarter results, the news outlet reported.

Novo Nordisk does not comment on market rumors, a company spokesman told Reuters. The spokesman added that the company regularly adjusts its business according to market conditions.